Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Inmune Bio, Inc. | Chief Scientific Officer, 10%+ Owner | Common Stock | 1.51M | $12.6M | $8.32 | Apr 19, 2024 | Direct |
Inmune Bio, Inc. | Chief Scientific Officer, 10%+ Owner | Option (right to buy) | 100K | May 14, 2024 | Direct | ||
Inmune Bio, Inc. | Chief Scientific Officer, 10%+ Owner | Common Stock Warrants (right to buy) | 14.4K | Apr 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INMB | Inmune Bio, Inc. | May 14, 2024 | 1 | $0 | 4 | May 16, 2024 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Apr 19, 2024 | 2 | $122K | 4/A | Apr 24, 2024 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Apr 19, 2024 | 2 | $122K | 4 | Apr 23, 2024 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Mar 21, 2022 | 2 | $199K | 4 | Mar 23, 2022 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Nov 3, 2021 | 1 | -$14K | 4 | Nov 4, 2021 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Oct 27, 2021 | 1 | -$47.1K | 4 | Oct 29, 2021 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Oct 22, 2021 | 1 | -$8K | 4 | Oct 26, 2021 | Chief Scientific Officer, 10%+ Owner |
INMB | Inmune Bio, Inc. | Jul 7, 2021 | 2 | -$605K | 4 | Jul 9, 2021 | Chief Scientific Officer |